cobalt, co

Cobalt is a transition metal and trace mineral that is essential to human life primarily as part of the vitamin B12 molecule. In its elemental or inorganic form, cobalt exists in oxidation states but is not used directly by human metabolism; instead, cobalt’s biological importance comes from its central role within cobalamin (vitamin B12), which is synthesized exclusively by certain bacteria and archaea. Humans and other animals cannot produce B12 or elemental cobalt, so cobalt enters the body through consumption of vitamin B12–containing foods or supplements. While cobalt is present in the Earth’s crust and widely distributed in foods in trace amounts, it is not used by human cells outside of vitamin B12. The discovery of cobalt’s essentiality stems from livestock studies where “bush sickness,” a fatal condition in sheep and cattle due to cobalt-poor soils, was prevented by cobalt supplementation, highlighting its importance for health. In humans, cobalt is found almost exclusively within vitamin B12. Because of this, dietary guidance and understanding of intake focus on vitamin B12 concentrations rather than elemental cobalt. No formal Recommended Dietary Allowance exists for cobalt alone, as sufficient intake is defined by adequate B12 levels, which for adults is 2.4 micrograms daily. Average adult diets in many populations naturally contain about 5–8 micrograms of cobalt per day through B12-rich sources. Cobalt as a chemical element has applications beyond nutrition, including in alloys for industrial use, pigments, and rechargeable batteries, but these forms are not suitable for dietary use. In nutrition, the term “cobalt” is often used interchangeably with the cobalt contained within vitamin B12, which is crucial for human health. In this role, cobalt helps with the synthesis of red blood cells, neurological function, and DNA metabolism. Trace amounts of cobalt are found in many foods, but the usable form for humans is that bound to vitamin B12. This means that most plant foods contribute negligible usable cobalt unless fortified. Understanding cobalt in the dietary context requires understanding vitamin B12 metabolism and its absorption, which involves intrinsic factor and specialized transport mechanisms. Without adequate B12 status, cobalt levels, and by extension B12 functionality, are insufficient. Because cobalt is essential in minute amounts, clinical deficiency of cobalt alone is almost always synonymous with severe vitamin B12 deficiency. This can occur due to malabsorption, intrinsic factor deficiency, or inadequate dietary intake, especially in strict vegetarian or vegan diets without appropriate B12 sources. Researchers continue to explore the broader roles of cobalt in human physiology and safe intake thresholds, but current clinical practice focuses on ensuring adequate vitamin B12 status rather than measuring cobalt independently.

The primary and almost exclusive function of cobalt in human biology is as the central metal ion in vitamin B12, also known as cobalamin. Within the B12 molecule, cobalt is coordinated in a corrin ring that facilitates key enzymatic reactions critical to human life. Vitamin B12-dependent enzymes include methionine synthase, which catalyzes the remethylation of homocysteine to methionine, a reaction essential for DNA synthesis and methylation pathways important for gene expression and cellular repair. A deficiency in this pathway leads to accumulation of homocysteine, which is associated with cardiovascular risk in observational studies. Another critical enzyme, methylmalonyl-CoA mutase, relies on B12 to convert methylmalonyl-CoA to succinyl-CoA, a step in fatty acid and amino acid metabolism. Impairment of this enzyme leads to accumulation of methylmalonic acid, which can be detected clinically as a marker of B12 deficiency and indicates dysfunctional metabolic processes. Red blood cell formation is a major function tied to cobalt via B12. Inadequate cobalt/B12 status results in defective DNA synthesis in hematopoietic precursors, leading to megaloblastic anemia characterized by large, immature red blood cells that are ineffective in oxygen transport. This contribution to erythropoiesis underscores why symptoms of deficiency include fatigue and pallor. Neurological functions are also closely tied to cobalt as part of B12: myelin sheath formation around neurons depends on B12, and long-term deficiency can result in irreversible nerve damage, presenting as peripheral neuropathy, cognitive changes, and balance difficulties. Beyond the well-established roles in blood and nerve health, emerging research suggests that adequate cobalt/B12 status supports energy metabolism, mood regulation, and cardiovascular health via homocysteine regulation. Some experimental studies have evaluated cobalt’s capacity to influence red blood cell production in hypoxic conditions, noting possible increases in erythropoietin, but these applications remain controversial due to safety concerns. Cobalt’s involvement in enzyme activation extends to other metabolic pathways, although these are secondary to the canonical roles tied to B12. In agriculture, cobalt supplementation in ruminant diets prevents deficiency diseases and supports growth, highlighting the trace metal’s broader biological importance, though direct translation to human nutrition emphasizes controlled intake within safe dietary exposure. It is important to differentiate between physiological and toxicological effects of cobalt. While cobalt as part of vitamin B12 is beneficial and necessary, exposure to high levels of inorganic cobalt (such as from industrial sources) is associated with cardiomyopathy, lung and thyroid dysfunction, and other adverse effects in occupational settings. Thus, health benefits are realized only within the narrow window of adequate but not excessive intake, typically achieved through diet and medically guided supplementation when necessary.

Unlike many other vitamins and minerals, there is no formal Recommended Dietary Allowance established solely for cobalt by authoritative bodies such as the NIH Office of Dietary Supplements. This is because cobalt’s nutritional role is primarily tied to vitamin B12 intake, which has an established RDA of 2.4 micrograms per day for adults. General dietary intake studies report average cobalt intakes of approximately 5 to 8 micrograms per day in adult populations consuming typical diets that include B12-rich foods. Infants, children, teens, and pregnant or lactating women do not have specific cobalt RDAs; instead, their needs are satisfied by meeting age-appropriate vitamin B12 recommendations. For example, pregnant women are advised to consume higher amounts of B12 to support fetal development, which by extension ensures adequate cobalt provision. Factors that affect cobalt needs include age, physiological status such as pregnancy or lactation, gastrointestinal health influencing vitamin B12 absorption, and dietary habits. Older adults often have reduced stomach acid and intrinsic factor production, impairing B12 absorption and effectively increasing requirements from diet or supplements to maintain adequate status. Individuals with gastrointestinal disorders (e.g., celiac disease, Crohn’s disease) or those who have undergone surgical procedures affecting the stomach or ileum also have higher risk of inadequate B12 and thus functional cobalt deficiency, making medical evaluation and targeted supplementation critical. Optimal intake is defined not by a numeric cobalt threshold but by maintaining serum vitamin B12 concentrations within established reference ranges that support hematologic and neurologic health. While average diets provide sufficient amounts, strict vegetarians, vegans, and individuals with absorption impairments may need fortified foods or B12 supplements to ensure adequate cobalt-related function. It is essential to distinguish between cobalt as an elemental nutrient and vitamin B12; elemental cobalt alone does not function unless incorporated into cobalamin. Healthcare providers assess needs based on clinical indicators of B12 status, symptoms, and laboratory markers, rather than measuring cobalt in isolation. Public health guidance focuses on meeting vitamin B12 intake recommendations because they inherently provide the necessary cobalt for physiologic processes without risk of excess elemental cobalt exposure, which is associated with toxicity at high doses. Therefore, while there is no formal numeric cobalt RDA, meeting vitamin B12 requirements is the practical proxy for sufficient cobalt intake.

True elemental cobalt deficiency is virtually synonymous with vitamin B12 deficiency in humans because cobalt’s only essential role is within the B12 molecule. Deficiency typically arises when B12 absorption or intake is inadequate. Classic clinical signs include megaloblastic anemia, characterized by large, immature red blood cells, fatigue, pallor, and shortness of breath. Neurological manifestations can be profound, involving peripheral neuropathy with symptoms such as numbness, tingling, burning sensations in the hands and feet, gait disturbances, balance problems, and cognitive changes including memory impairment and mood disturbances. Severe deficiency can produce irreversible neurological damage if not treated promptly. Gastrointestinal symptoms may include glossitis (smooth, red tongue), appetite loss, weight loss, and diarrhea or constipation. Biochemical indicators of deficiency include elevated homocysteine and methylmalonic acid levels, which reflect impaired B12-dependent enzyme activity. Subclinical deficiency without overt anemia may present with subtle neurologic complaints or unexplained fatigue, often in older adults or those with malabsorption conditions. Populations at risk for deficiency include strict vegetarians or vegans without adequate fortified foods or supplements, older adults with reduced intrinsic factor, and individuals with gastrointestinal disorders affecting absorption. Prevalence statistics vary widely depending on the population studied and diagnostic criteria, but B12 deficiency increases with age, with significant prevalence in elderly populations, particularly those in institutional settings. Deficiency rates can be as high as 10–15% in older adults and greater than 20% in those with pernicious anemia or significant gastric pathology. Laboratory tests for deficiency include serum vitamin B12 concentration, methylmalonic acid, and homocysteine. Reference ranges for vitamin B12 typically consider levels below 200 pg/mL as deficient, with functional deficiency potentially occurring at higher values depending on clinical context. Because cobalt status per se is not measured routinely, focus on B12 assessment provides the most clinically relevant picture of deficiency.

Because usable cobalt in human nutrition is found within vitamin B12, the richest food sources are those high in B12. Organ meats, particularly beef liver and kidney, are among the densest dietary sources, delivering significant amounts of B12 and thus cobalt. Shellfish such as clams, oysters, and mussels also provide high vitamin B12 concentrations. Other animal-sourced foods including fish (sardines, salmon, tuna), red meat, poultry, eggs, and dairy products (milk, cheese, yogurt) contribute meaningful amounts of cobalt via B12 content. Clams, for example, are often highlighted as one of the highest B12-containing foods per serving, making them excellent sources for individuals seeking to boost cobalt intake through B12-rich foods. Plant-based foods generally do not contain vitamin B12 unless fortified, since B12-producing microorganisms are absent in plants. However, certain plant foods may contain trace amounts of elemental cobalt depending on soil mineral content, including legumes, whole grains, nuts, seeds, and leafy greens. Studies analyzing cobalt content have found beans (dry red, brown, pinto) to contain measurable micrograms of cobalt per 100 g dry weight, though the bioavailability and conversion into B12 are limited. For this reason, vegetarians and vegans are often advised to consume B12-fortified foods such as fortified cereals, plant-based milks, and nutritional yeast to ensure sufficient cobalt in a usable form. Preparation and processing can affect cobalt/B12 content. Cooking and food processing may reduce vitamin B12 levels, so consuming a variety of unprocessed or minimally processed foods ensures higher retention. Additionally, combining food sources with vitamin C–rich fruits and vegetables enhances overall nutrient absorption and supports hematologic health. Special attention should be given to individuals with higher requirements, such as older adults, pregnant and lactating women, and those with malabsorptive disorders, to tailor food choices that meet their needs.

The absorption of cobalt from food is intrinsically linked to the absorption of vitamin B12. Dietary B12 is bound to protein in foods and is released by gastric acid and pepsin in the stomach. Once freed, B12 binds to intrinsic factor, a glycoprotein produced by parietal cells in the stomach. This complex travels to the terminal ileum, where specific receptors facilitate absorption into enterocytes. Any disruption in this process, such as atrophic gastritis, pernicious anemia (autoimmune loss of intrinsic factor), or surgical removal of parts of the stomach or ileum, significantly impairs B12 absorption and consequently cobalt utilization. Bioavailability of cobalt from B12 is high when intrinsic factor mechanisms are intact, but it declines with age and certain medical conditions. In contrast, elemental cobalt or cobalt salts do not contribute meaningfully to B12 status and are poorly utilized; in fact, high levels of inorganic cobalt can be toxic. Fortified foods containing crystalline B12 forms (such as cyanocobalamin or methylcobalamin) are absorbed via passive diffusion at high doses but otherwise follow the intrinsic factor–mediated pathway. Once absorbed, B12 is bound to transport proteins in the blood (transcobalamins) and delivered to tissues. B12 storage in the liver provides a significant reservoir that can last years, delaying clinical deficiency despite low intake. Factors that enhance B12 absorption include adequate stomach acid production, intrinsic factor levels, and healthy ileal mucosa. Medications such as proton pump inhibitors and metformin can reduce B12 absorption over time by altering gastric environment or interfering with absorption, leading to functional cobalt/B12 deficiency if not monitored. Interactions with folate metabolism also influence B12 function, with imbalances potentially masking hematologic signs of deficiency while allowing neurologic damage to progress.

Standalone cobalt supplements are not recommended for the general population because cobalt’s essential role is fulfilled through vitamin B12 intake. Supplements containing cobalt in forms other than B12 (e.g., cobalt salts) have not demonstrated clear benefits and carry safety concerns at higher doses. For individuals with diagnosed vitamin B12 deficiency or specific absorption issues, B12 supplements (containing cyanocobalamin, methylcobalamin, or other cobalamin forms) are appropriate and evidence-based to restore B12 and functional cobalt status. These supplements bypass dietary limitations and, when taken with medical guidance, correct deficiency and prevent associated hematologic and neurologic complications. When considering supplementation, form matters. Cyanocobalamin and methylcobalamin are common forms with good bioavailability; hydroxocobalamin is another form used clinically, especially in injectable preparations for pernicious anemia. Oral high-dose B12 may be useful for individuals with partial absorption issues, while intramuscular injections are reserved for severe deficiency or malabsorption. Typical supplemental doses vary with need: maintenance doses often match or slightly exceed RDAs, whereas therapeutic repletion may require higher medically supervised doses. Supplements should be considered for individuals at risk of deficiency: strict vegetarians or vegans, older adults with reduced intrinsic factor production, those with gastrointestinal disorders, individuals on medications that impair absorption, and pregnant or lactating women with inadequate dietary intake. Supplements are most effective when taken consistently, often with meals to optimize tolerance, though timing relative to food is less critical for B12 absorption given its intrinsic factor–mediated pathway. Healthcare providers tailor doses based on laboratory markers and clinical response. Because cobalt status is not measured directly, monitoring focuses on B12 levels, methylmalonic acid, and homocysteine.

There is no established tolerable upper intake level (UL) for cobalt itself because it is not treated as a stand‑alone dietary nutrient with an RDA. However, evidence indicates that excessive intake of inorganic cobalt compounds can be toxic. Industrial exposure to cobalt dust or soluble cobalt salts has been associated with cardiomyopathy, lung disease, thyroid dysfunction, and skin and lung sensitization at high levels. Historical cases of cardiomyopathy occurred in populations consuming cobalt‑fortified beer at high levels, underscoring the risks of excessive exposure. Clinical manifestations of cobalt toxicity from non‑nutritional sources include heart failure, polycythemia (too many red blood cells), neurologic symptoms, goiter, and thyroid hormone disruption. In the dietary context, excessive intake is unlikely from food alone because usable cobalt is limited to what is bound within vitamin B12; even high‑B12 foods do not supply cobalt in amounts approaching toxicity thresholds. However, high supplemental doses of cobalt salts outside the context of B12 supplementation should be avoided. The boundary between adequate and harmful doses is narrow when using cobalt salts, which is why these forms are not recommended without medical supervision. In clinical settings where cobalt is part of B12 supplements, toxicity is rare when doses are within therapeutic ranges and monitored appropriately. Symptoms of excessive cobalt exposure include nausea, vomiting, diarrhea, tinnitus (ringing in the ears), cognitive changes, and cardiomyopathy in severe cases. Because cobalt accumulates in certain tissues, particularly the heart and endocrine organs, chronic high exposure carries significant health risks. Individuals exposed occupationally to cobalt should use protective equipment and monitor blood levels as recommended. Overall, safe dietary intake through balanced food consumption and medically guided B12 supplementation minimizes risk while ensuring essential nutritional needs.

Cobalt’s nutritional function is mediated through vitamin B12; therefore, interactions are most commonly those that affect B12 absorption and utilization rather than cobalt directly. Medications such as proton pump inhibitors (PPIs) and histamine‑2 receptor blockers used for gastroesophageal reflux disease reduce gastric acid secretion, impairing release of B12 from food proteins and potentially leading to functional cobalt/B12 deficiency over long‑term use. Metformin, a common diabetes medication, has been associated with reduced B12 absorption, which can contribute to anemia and neuropathy if not monitored and supplemented appropriately. Certain antibiotics and cholestyramine may interfere with B12 absorption when taken concomitantly, reducing cobalt/B12 uptake. Folate supplementation in high doses can mask hematologic signs of B12 deficiency, delaying diagnosis while neurologic damage progresses. Individuals taking these medications, especially long‑term, should have periodic assessment of B12 status and consider fortified foods or supplements as advised by clinicians. There are no well‑documented direct interactions between cobalt supplementation (as part of B12) and other medications when used within recommended therapeutic doses, but caution is warranted with high Supplemental use of cobalt salts outside of B12 formulations due to potential toxicities.

Common Forms: Cyanocobalamin, Methylcobalamin, Hydroxocobalamin

Typical Doses: Matching B12 RDA or higher for deficiency (as directed)

When to Take: Daily with meals or as advised by clinician

Best Form: Methylcobalamin for oral supplementation

⚠️ Interactions: Proton pump inhibitors, Metformin, High-dose folate